Ureka is a leading pharmaceutical company in foldamer peptidomimetics. Our focus is on transforming peptides into treatments. As peptides are natural messengers of living organisms, they are ideal molecules for pharmaceutical development as they are by nature compatible with life.
Ureka’s proprietary UrelixTM technologies involve taking lead peptides and optimize
their pharmaceutical properties to generate the best drug candidates.